A detailed history of Johnson Financial Group, Inc. transactions in Artivion, Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 148 shares of AORT stock, worth $4,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
148
Previous 190 22.11%
Holding current value
$4,420
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$25.41 - $30.11 $1,067 - $1,264
-42 Reduced 22.11%
148 $4,000
Q3 2024

Nov 13, 2024

BUY
$24.33 - $28.46 $4,622 - $5,407
190 New
190 $5,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.2B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.